Therefore, other than existing cytotoxic chemotherapy drugs, HDAC inhibitors may redirect cancer cells back into the normal colonic life cycle of cell differentiation and apoptosis, implicating a rational and promising strategy for colon cancer therapy. This evidence concerns the gene HDAC9 and colonic neoplasm.